Literature DB >> 25044704

Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention.

Laura M Beaver1, Alex Buchanan, Elizabeth I Sokolowski, Allison N Riscoe, Carmen P Wong, Jeff H Chang, Christiane V Löhr, David E Williams, Roderick H Dashwood, Emily Ho.   

Abstract

SCOPE: Epidemiological studies provide evidence that consumption of cruciferous vegetables, like broccoli, can reduce the risk of cancer development. Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that induces anti-proliferative and pro-apoptotic responses in prostate cancer cells, but not in normal prostate cells. The mechanisms responsible for this cancer-specific cytotoxicity remain unclear. METHODS AND
RESULTS: We utilized RNA sequencing and determined the transcriptomes of normal prostate epithelial cells, androgen-dependent prostate cancer cells, and androgen-independent prostate cancer cells treated with SFN. SFN treatment dynamically altered gene expression and resulted in distinct transcriptome profiles depending on prostate cell line. SFN also down-regulated the expression of genes that were up-regulated in prostate cancer cells. Network analysis of genes altered by SFN treatment revealed that the transcription factor Specificity protein 1 (Sp1) was present in an average of 90.5% of networks. Sp1 protein was significantly decreased by SFN treatment in prostate cancer cells and Sp1 may be an important mediator of SFN-induced changes in expression.
CONCLUSION: Overall, the data show that SFN alters gene expression differentially in normal and cancer cells with key targets in chemopreventive processes, making it a promising dietary anti-cancer agent.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Chemoprevention; Prostate cancer; RNA sequencing; Specificity protein 1; Sulforaphane

Mesh:

Substances:

Year:  2014        PMID: 25044704      PMCID: PMC4184971          DOI: 10.1002/mnfr.201400269

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  43 in total

Review 1.  The role of Sp1 and Sp3 in normal and cancer cell biology.

Authors:  Lin Li; James R Davie
Journal:  Ann Anat       Date:  2010-08-06       Impact factor: 2.698

Review 2.  Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis.

Authors:  Ben Liu; Qiqi Mao; Min Cao; Liping Xie
Journal:  Int J Urol       Date:  2011-11-28       Impact factor: 3.369

Review 3.  Targeting Sp1 transcription factors in prostate cancer therapy.

Authors:  Umesh T Sankpal; Steven Goodison; Maen Abdelrahim; Riyaz Basha
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

4.  Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.

Authors:  Shivendra V Singh; Renaud Warin; Dong Xiao; Anna A Powolny; Silvia D Stan; Julie A Arlotti; Yan Zeng; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Dhimant Desai; Shantu Amin; Robert A Parise; Jan H Beumer; William H Chambers
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

5.  3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.

Authors:  Chibo Hong; Hyeon-A Kim; Gary L Firestone; Leonard F Bjeldanes
Journal:  Carcinogenesis       Date:  2002-08       Impact factor: 4.944

6.  In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat.

Authors:  Rong Hu; Vidya Hebbar; Bok-Ryang Kim; Chi Chen; Bozena Winnik; Brian Buckley; Patricia Soteropoulos; Peter Tolias; Ronald P Hart; A-N Tony Kong
Journal:  J Pharmacol Exp Ther       Date:  2004-02-26       Impact factor: 4.030

7.  Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

Authors:  Roble G Bedolla; Jingjing Gong; Thomas J Prihoda; I-Tien Yeh; Ian M Thompson; Rita Ghosh; Addanki P Kumar
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

8.  The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer.

Authors:  Maria H Traka; Caroline A Spinks; Joanne F Doleman; Antonietta Melchini; Richard Y Ball; Robert D Mills; Richard F Mithen
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

9.  BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams.

Authors:  Tim Hulsen; Jacob de Vlieg; Wynand Alkema
Journal:  BMC Genomics       Date:  2008-10-16       Impact factor: 3.969

10.  Transcriptome sequencing to detect gene fusions in cancer.

Authors:  Christopher A Maher; Chandan Kumar-Sinha; Xuhong Cao; Shanker Kalyana-Sundaram; Bo Han; Xiaojun Jing; Lee Sam; Terrence Barrette; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

View more
  12 in total

1.  Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.

Authors:  Zhenzhen Zhang; Mark Garzotto; Edward W Davis; Motomi Mori; Wesley A Stoller; Paige E Farris; Carmen P Wong; Laura M Beaver; George V Thomas; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho; Jackilen Shannon
Journal:  Nutr Cancer       Date:  2019-06-01       Impact factor: 2.900

2.  Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer.

Authors:  Laura M Beaver; Rachael Kuintzle; Alex Buchanan; Michelle W Wiley; Sarah T Glasser; Carmen P Wong; Gavin S Johnson; Jeff H Chang; Christiane V Löhr; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho
Journal:  J Nutr Biochem       Date:  2017-01-12       Impact factor: 6.048

3.  A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.

Authors:  Gavin S Johnson; Jia Li; Laura M Beaver; W Mohaiza Dashwood; Deqiang Sun; Praveen Rajendran; David E Williams; Emily Ho; Roderick H Dashwood
Journal:  Mol Nutr Food Res       Date:  2017-01-03       Impact factor: 5.914

4.  Serine/threonine kinase 32C is overexpressed in bladder cancer and contributes to tumor progression.

Authors:  Erlin Sun; Kangkang Liu; Kun Zhao; Lining Wang
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

5.  Assessment of global proteome in LNCaP cells by 2D-RP/RP LC-MS/MS following sulforaphane exposure.

Authors:  Gregory W Watson; Samanthi Wickramasekara; Claudia S Maier; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  EuPA Open Proteom       Date:  2015-08-10

6.  Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma.

Authors:  Srinivasulu Yerukala Sathipati; Divya Sahu; Hsuan-Cheng Huang; Yenching Lin; Shinn-Ying Ho
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

7.  Role of Sp1 expression in gastric cancer: A meta-analysis and bioinformatics analysis.

Authors:  Shuai Shi; Zhi-Gang Zhang
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

8.  Sulforaphane-Induced Klf9/Prdx6 Axis Acts as a Molecular Switch to Control Redox Signaling and Determines Fate of Cells.

Authors:  Bhavana Chhunchha; Eri Kubo; Dhirendra P Singh
Journal:  Cells       Date:  2019-09-27       Impact factor: 6.600

9.  Effects of Antioxidants in Human Cancers: Differential Effects on Non-Coding Intronic RNA Expression.

Authors:  Shreya Menon; Chunxia Lu; Rajasree Menon; Jessica Schwartz; Yuanfang Guan
Journal:  Antioxidants (Basel)       Date:  2016-01-04

10.  Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress.

Authors:  Eri Kubo; Bhavana Chhunchha; Prerna Singh; Hiroshi Sasaki; Dhirendra P Singh
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.